BioLink Life Sciences, Inc.

11:30 AM - 11:45 AM, Thursday, June 6, 2019 ・ Theater 2
BioLink Life Sciences is a biopharmaceutical technology company targeting major chronic diseases with innovative drug treatments. BioLink’s exclusive drug therapies support disease management initiatives to enhance the quality of life and care of patients while improving patient tolerability and decreasing drug costs. The Company is developing a robust pipeline of novel treatments for osteoporosis, iron deficiencies, kidney disease, diabetes, and seizure disorders. The NDA for Phosveda(R), a treatment for hyperphosphatemia, is under FDA review. Submissions for New Dietary Ingredients have been presented to the FDA.
Ticker:
Not Provided.
Exchange:
Not Provided.
Company Type:
Company Website:
Company HQ State:
North Carolina
Company HQ Country:
United States
Year Founded:
2001
Main Therapeutic Focus:
Lead Product in Development:
Active Sr (strontium lactate)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
photo
President
BioLink Life Sciences, Inc.